Presentation is loading. Please wait.

Presentation is loading. Please wait.

John A. Eckman, MD, Patricia M

Published byBuck Porter Modified over 5 years ago

Similar presentations

Presentation on theme: "John A. Eckman, MD, Patricia M"— Presentation transcript:

1 Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge 
John A. Eckman, MD, Patricia M. Sterba, MS, Denise Kelly, RN, BSN, Val Alexander, BS, Mark C. Liu, MD, Bruce S. Bochner, MD, Donald W. MacGlashan, MD, PhD, Sarbjit S. Saini, MD  Journal of Allergy and Clinical Immunology  Volume 125, Issue 4, Pages e7 (April 2010) DOI: /j.jaci Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Overall study design. ∗Midstudy NAC and SPTT occurred when cat allergen BHR was <20% of baseline or ∼ day 45. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Cat allergen–induced BHR in omalizumab (n = 12; A) and placebo recipients (n = 4; B) relative to the day of study. All comparisons are within each group relative to relative to the response measured at baseline (day 0) by 2-tailed paired t test. Error bars, SEM. ∗P < .05; ∗∗P < .01; #P < .001; ‡P < Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 The percent of cat allergen–specific IgE to total IgE is correlated to the timing of the midstudy NAC for subjects receiving omalizumab. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig 4 Average VAS score in omalizumab-treated (n = 12; A) subjects grouped according to the dose of allergen and NAC visit. Average sneeze counts in omalizumab treated (n = 12; B) and placebo-treated subjects (n = 4; C) grouped according to the dose of allergen and NAC visit. PGD2 levels in nasal lavage for each NAC allergen dose at the 3 NAC time points in actively treated subjects (n = 11; D). Closed circles, Baseline NAC; closed squares, midstudy NAC; open circles, final NAC; error bars, SEM. ∗P < .05; ∗∗P < .01; #P < .001; ‡P < .0001. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig 5 Average SPT flare size in omalizumab (n = 12; A) and placebo (n = 4; B)–treated subjects at the time of indicated NAC. Error bars, SEM. ∗P < .05; 2-tailed, paired t test compared with baseline SPT value. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

7 Average VAS score in placebo-treated (n = 4) subjects grouped according to the dose of allergen and NAC visit. Error bars, SEM. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

8 PGD2 levels in nasal lavage for each NAC allergen dose at the baseline (closed circle) and final (open circle) NAC time points in placebo-treated subjects (n = 3). Error bars, SEM. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

9 Average SPT wheal size in omalizumab-treated (n = 12) subjects at the time of indicated NAC. ∗P < .05; 2-tailed, paired t test compared with baseline SPT value. Error bars, SEM. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

10 Average SPT wheal size in placebo-treated subjects (n = 4) subjects at the time of indicated NAC. Error bars, SEM. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "John A. Eckman, MD, Patricia M"

Similar presentations

Buffering airway acid decreases exhaled nitric oxide in asthma Benjamin Gaston, MD, Robin Kelly, RN, Peter Urban, RN, Lei Liu, PhD, Edward M. Henderson,

Buffering airway acid decreases exhaled nitric oxide in asthma Benjamin Gaston, MD, Robin Kelly, RN, Peter Urban, RN, Lei Liu, PhD, Edward M. Henderson,
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.

Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.
Nasal challenge with allergen leads to maxillary sinus inflammation

Nasal challenge with allergen leads to maxillary sinus inflammation
Repeated low-dose intradermal allergen injection suppresses allergen-induced cutaneous late responses  Giuseppina Rotiroti, MD, Mohamed Shamji, PhD, Stephen.

Repeated low-dose intradermal allergen injection suppresses allergen-induced cutaneous late responses  Giuseppina Rotiroti, MD, Mohamed Shamji, PhD, Stephen.
Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery  Albertien A.C. Aukema,

Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery  Albertien A.C. Aukema,
A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy  Satya D. Narisety,

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy  Satya D. Narisety,
High-titer IgE antibody specific for pollen allergens in northern California is associated with both wheezing and total serum IgE  Elizabeth A. Erwin,

High-titer IgE antibody specific for pollen allergens in northern California is associated with both wheezing and total serum IgE  Elizabeth A. Erwin,
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy  Michael Kulis, PhD, Katie.

Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy  Michael Kulis, PhD, Katie.
Petasol butenoate complex (Ze 339) relieves allergic rhinitis–induced nasal obstruction more effectively than desloratadine  Alina F. Dumitru, MD, Mohamed.

Petasol butenoate complex (Ze 339) relieves allergic rhinitis–induced nasal obstruction more effectively than desloratadine  Alina F. Dumitru, MD, Mohamed.
Ibrutinib, a Bruton’s tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil.

Ibrutinib, a Bruton’s tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil.
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study  John M. Brehm, MD, MPH, Brooke Schuemann, BS,

Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study  John M. Brehm, MD, MPH, Brooke Schuemann, BS,
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy  Robert A.

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy  Robert A.
Preventive effect of nasal filters on allergic rhinitis: A randomized, double-blind, placebo- controlled crossover park study  Peter Kenney, BSc, Ole Hilberg,

Preventive effect of nasal filters on allergic rhinitis: A randomized, double-blind, placebo- controlled crossover park study  Peter Kenney, BSc, Ole Hilberg,
Bruce M. Prenner, MD, Bobby Q. Lanier, MD, David I

Bruce M. Prenner, MD, Bobby Q. Lanier, MD, David I
The effects of house dust mite sublingual immunotherapy tablet on immunologic biomarkers and nasal allergen challenge symptoms  Natasha C. Gunawardana,

The effects of house dust mite sublingual immunotherapy tablet on immunologic biomarkers and nasal allergen challenge symptoms  Natasha C. Gunawardana,
Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils  Henry Lin, MD, Kevin M Boesel, MD, Daniel T Griffith, MD, Calman Prussin,

Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils  Henry Lin, MD, Kevin M Boesel, MD, Daniel T Griffith, MD, Calman Prussin,
Basophil FcɛRI histamine release parallels expression of Src-homology 2–containing inositol phosphatases in chronic idiopathic urticaria  Becky M. Vonakis,

Basophil FcɛRI histamine release parallels expression of Src-homology 2–containing inositol phosphatases in chronic idiopathic urticaria  Becky M. Vonakis,

Similar presentations

Ads by Google